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Persistent changes in synaptic strength are locally
regulated by both protein degradation and synthesis;
however, the coordination of these opposing limbs
is poorly understood. Here, we found that the RISC
protein MOV10 was present at synapses and was
rapidly degraded by the proteasome in an NMDA-
receptor-mediated activity-dependent manner. We
designeda translational trap to capture thosemRNAs
whose spatiotemporal translation is regulated by
MOV10. When MOV10 was suppressed, a set of
mRNAs—including a-CaMKII, Limk1, and the depal-
mitoylating enzyme lysophospholipase1 (Lypla1)—
selectively entered the polysome compartment. We
also observed that Lypla1 mRNA is associated
with the brain-enriched microRNA miR-138. Using
a photoconvertible translation reporter, Kaede, we
analyzed the activity-dependent protein synthesis
driven by Lypla1 and a-CaMKII 30UTRs. We estab-
lished this protein synthesis to beMOV10 andprotea-
some dependent. These results suggest a unifying
picture of a local translational regulatory mechanism
during synaptic plasticity.
INTRODUCTION
The ubiquitin-proteasome system (UPS) is an important modu-
lator of several neuronal functions, including growth cone
guidance, synapse development, and plasticity (Bingol and
Schuman, 2005; DiAntonio et al., 2001; Patrick, 2006; Tai and
Schuman, 2008; Yi and Ehlers, 2007). Dysregulation of protea-
some-mediated degradation by mutating a specific ubiquitin
ligase impaired LTP and contextual learning (Jiang et al.,
1998). The injection of a proteasome inhibitor into hippocampal
CA1 resulted in impairment of some hippocampal-dependent
memory tasks (Lopez-Salon et al., 2001). The proteasome
machinery can also regulate activity-dependent remodeling of
the postsynaptic density by incorporating or removing master
organizing molecules such as scaffolding proteins, glutamate
receptors, and signaling enzymes (Ageta et al., 2001; Ehlers,2003; Yi and Ehlers, 2005). These observations suggest a link
between localized protein degradation and synthesis in the
regulation of synaptic plasticity. In support of this link, protea-
some blockade can diminish late-phase LTP (L-LTP) induced
at Schaffer collateral-CA1 synapses, like pharmacological inhibi-
tion of translation (Fonseca et al., 2006). Interestingly, coapplica-
tion of proteasome blockers with translation inhibitors largely
restores L-LTP, suggesting the need for a crucial balance
between protein degradation and synthesis for maintenance of
L-LTP (Fonseca et al., 2006). Furthermore, activity-dependent
relocation of the proteasome from the dendritic shaft to the
synaptic spine resulted in a spatially precise loss of a degradation
reporter (Bingol and Schuman, 2006). The relocation of UPS
components is reminiscent of polyribosome redistribution in
potentiated spines (Ostroff et al., 2002) and suggests local
remodeling of the spine through coordinated degradation and
synthesis. A likely target of activity-mediated degradation is
Armitage. In Drosophila, this key RNA-induced silencing
complex (RISC) factor undergoes rapid degradation in response
to a specific olfactory learning paradigm (Ashraf et al., 2006). The
activity-dependent loss of Armitage released translationally
suppressed synaptic mRNAs such as CaMKII, whose translation
is associated with stable memory (Ashraf et al., 2006). However,
candidate mRNAs that are regulated by coordinated protein
degradation and synthesis within the synaptodendritic compart-
ment in the mammalian central nervous system (CNS) remain
elusive.
Here, we found that MOV10, a homolog of the Drosophila
DExD-box protein Armitage (Meister et al., 2005), was present
at synapses and was rapidly degraded by the proteasome in an
NMDA-receptor-mediated activity-dependent manner. To iden-
tify RISC-regulated candidate synaptic mRNAs, we designed
a translational trap that captured mRNAs in the polyribosome
fraction after RNAi knockdown of MOV10. We found, among
others, two known RISC-associated synaptic mRNAs–a-CaMKII
and LimK1 (Ashraf et al., 2006; Schratt et al., 2006)—as well as
lypophospholipase 1 (Lypla1), a depalymitoylating enzyme. We
also observed that Lypla1 mRNA is associated with the brain-
enriched microRNA miR-138. Using a photoconvertible transla-
tion reporter, Kaede, we analyzed the activity-dependent protein
synthesis driven by Lypla1 and a-CaMKII 30UTRs. We estab-
lished this protein synthesis to be MOV10 and proteasome
dependent. These results point toward a comprehensive pictureNeuron 64, 871–884, December 24, 2009 ª2009 Elsevier Inc. 871
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Figure 1. Synaptic Localization of MOV10 and Its Activity-Dependent Proteasomal Degradation
(A) Synaptic localization of endogenous MOV10. DIV 21 neurons were immunostained with MOV10 and PSD95 antibodies. MOV10 shows a punctate pattern
along dendrites that colocalized with the synaptic marker PSD95. Neurite processes are shown in outline. Scale bar, 100 mm.
(B) High-resolution image from the indicated region of (A). Scale bar, 20 mm.
(C) Endogenous MOV10 (130 and 95 kDa) is localized in the synaptodendritic compartment. Synaptoneurosomes (SN) were prepared from 5- to 6-week-old
rat hippocampi (Crude: total hippocampal lysate).
(D) Proteasomal control of MOV10 degradation is regulated through the NMDA receptor. Hippocampal neurons (DIV 21–23) were stimulated by 60 mM KCl or
20 mM NMDA for 5 min. The block of proteasome activity by lactacystin (10 mM, 10 min pretreatment) or NMDA antagonist AP5 (50 mM, 50 min pretreatment)
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MOV10 Degradation and Translational Silencingof a local translational regulatory mechanism during synaptic
plasticity.RESULTS
Synaptic Localization of MOV10
The SDE3 helicase Armitage, member of the RISC, has been
shown to regulate synaptic protein synthesis in D. melanogaster
(Ashraf et al., 2006). We first showed the synaptic localization of
the mammalian ortholog of Armitage, MOV10. Rat hippocampal
neurons (DIV 21) were immunostained for MOV10, and synapses
were identified with the postsynaptic marker PSD95 (Figures 1A
and 1B). MOV10 pattern was punctate. 62.8% ± 4.0% of PSD95
puncta colocalized with MOV10 puncta and 25% ± 1.6% of
MOV10 puncta colocalized with PSD95. MOV10 puncta were
also present within dendrites (Figure S1C). A biochemical anal-
ysis of synaptoneurosomes prepared from rat hippocampi
confirmed the synaptodendritic localization of endogenous
MOV10 (Figure 1C). Similarly, immunostaining of cultured rat
hippocampal neurons expressing MOV10 tagged with photoac-
tivatable GFP (MOV10-PA-GFP) (Patterson and Lippincott-
Schwartz, 2002) (Figures S1D and S1E) showed a similar
punctate pattern, with 45.6% ± 3.2% of PSD95 puncta colocal-
ized to MOV10-PA-GFP and 73.2% ± 3.6% of MOV10-PA-GFP
puncta colocalized to PSD95 (Figures S1D and S1E). Relative
to endogenousMOV10,MOV10-PA-GFP appears to have a rela-
tive preference for synapses; however, using antibodies against
GFP and MOV10, we observed 64.6% ± 1.3% colocalization
between endogenous MOV10 puncta and ectopic MOV10-PA-
GFP puncta (Figure S1F), suggesting similar localizations for
both endogenous and ectopically expressed MOV10. Further-
more, ectopic expression of MOV10-PA-GFP did not alter the
protein level of another key RISC component, Argonaute (Nelson
et al., 2007) (Figure S2E).
Activity-Dependent Degradation of MOV10
To investigate activity-dependent regulation of MOV10, we
depolarized hippocampal neurons with KCl (60 mM, 5 min) and
observed that endogenous MOV10 was rapidly degraded within
30 min (only 38.5% ± 8.1% of the MOV10-immunoreactive band
remained intact compared to its basal level, p = 0.0006, t test,
Figure 1D). Pretreatment of neurons with the proteasome inhib-
itor lactacystin (10 mM, 10 min) significantly rescued this effect
(75.4% ± 11.2% of MOV10 was unchanged, p = 0.024, t test,
Figure 1D). Lactacystin alone without stimulation did not cause
any significant loss of MOV10 levels (83% ± 8.3% of MOV10prevented KCl-induced MOV10 degradation. NMDA (20 mM, 5 min) stimulation
pretreatment). Data shown as mean ± SEM (KCl stimulation: n = 8; NMDA stimu
(E) Synaptic degradation of endogenous MOV10. Synaptoneurosomal fraction wa
ulated with KCl (60 mM, 10 min). Lactacystin (10 mM, 15 min pretreatment) or NM
degradation. Data shown as mean ± SEM, n = 3, *p < 0.05, t test.
(F) Activity-regulated degradation of MOV10 by ubiquitin-dependent 26S prote
(GFP-Ub) or mutant (GFP-UbKO) ubiquitin. GFP- Ub and GFP-UbKO expressing n
prevented KCl-induced degradation of MOV10.
(G) Ubiquitination of MOV10. MOV10-PA-GFP complex was immunoprecipitated
pretreated with lactacystin (10 mM, 10 min) and stimulated with 60 mM KCl for 5
were then analyzed by western blot using antibodies specific for polyubiquitin cowas unchanged, p = 0.097, t test) (Figure S2A). Furthermore,
we observed comparable degradation of ectopically expressed
PA-GFP-tagged MOV10 upon neuronal stimulation (only 37% ±
7.1% of MOV10-PA-GFP remained intact, p = 0.002, t test,
Figure S2B). Thus, like its fly ortholog, MOV10 is degraded by
the proteasome in an activity-dependent manner.
However, depolarization with KCl activates many voltage- and
ligand-gated channels, including the NMDA-type glutamate
receptor, which plays a significant role in synaptic plasticity in
the CNS. Therefore, we tested whether the NMDA receptor
is involved in the proteasomal degradation of MOV10 by
treating neurons with its antagonist, AP5 (D(-)-2-amino-5-phos-
phonovaleric acid) (50 mM, 50min) (Figure 1D). AP5 pretreatment
significantly prevented the KCl-induced loss of MOV10 (73.1% ±
8.8% of MOV10 was unchanged, p = 0.018, t test, Figure 1D).
AP5 treatment without stimulation did not produce significant
changes in MOV10 levels (81% ± 18% of MOV10 was
unchanged, p = 0.30, Figure S2A). Consistent with this observa-
tion, neuronal stimulation by NMDA alone (20 mM, 5 min) was
sufficient to induce rapid degradation of endogenous MOV10
(only 22% ± 5.6% of MOV10 remained intact, p = 0.002, t test,
Figure 1D). This NMDA-mediated degradation was rescued
by lactacystin (86% ± 7.3% of MOV10 was unchanged,
p = 0.002, t test, Figure 1D). These results suggested that
NMDA activity can induce activity-dependent proteasomal
regulation of MOV10 in the mammalian CNS.
If MOV10 degradation regulates synaptic plasticity by
releasing miRNA-mediated translational repression at synaptic
sites upon neuronal activity, we expect endogenous MOV10 to
be degraded locally in the synaptodendritic compartment.
Biochemical analyses of synaptoneurosomes prepared from
stimulated slices (60 mMKCl, 10 min) showed rapid degradation
of MOV10 (only 16% ± 4.6% of MOV10 remained intact, p =
0.0036, t test, Figures 1E and S2F), and this rapid loss of
MOV10 was rescued by lactacystin (10 mM, 15 min) (77.4% ±
8.1% of MOV10 was unchanged, p = 0.0028, t test, Figure 1E).
Similarly, AP5 (50 mM, 60 min) also prevented the rapid
synaptic degradation of MOV10 (79.3% ± 9.3% of MOV10 was
unchanged, p = 0.003, t test, Figure 1E). Together, these
biochemical observations suggest that activity-regulated pro-
teasomal degradation of MOV10 can occur locally at synaptic
sites after NMDA receptor activation.
MOV10 Degradation Is Ubiquitin Dependent
Neuronal protein turnover is regulated in both a ubiquitin-depen-
dent and -independent manner (Tai and Schuman, 2008). To
determine whether ubiquitination is required for MOV10induced MOV10 degradation that was rescued by lactacystin (10 mM, 10 min
lation: n = 6), *p < 0.05, t test.
s prepared from hippocampal slices from 5- to 6-week-old rats that were stim-
DA inactivation by AP5 (50 mM, 60 min pretreatment) rescued the KCl-induced
asome. Hippocampal neurons were transduced with GFP fused to wild-type
eurons (DIV 21) were stimulated with KCl (60 mM, 5 min). The ubiquitin mutant
from DIV 21–24 neurons (transduced with MOV10-PA-GFP) that were either
min or incubated under basal conditions. The immunoprecipitated complexes
njugates and GFP.
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MOV10 Degradation and Translational Silencingdegradation, we expressed GFP-fused ubiquitin mutant with all
seven lysines replaced by arginine (GFP-UbKO) or GFP-fused
wild-type ubiquitin (GFP-Ub) (Bergink et al., 2006) in hippo-
campal neurons. GFP-UbKO has been shown to prevent
ubiquitin-dependent proteasomal degradation by blocking
polyubiquitination of the target protein (Bergink et al., 2006).
Then we depolarized neurons expressing GFP-Ub or GFP-
UbKO. After depolarization, MOV10 degradation was efficiently
blocked in neurons expressing the ubiquitin mutant, but not
wild-type ubiquitin (Figure 1F), thereby suggesting that
activity-regulated MOV10 degradation occurs in a ubiquitin-
dependent manner.
To analyze further the ubiquitination of MOV10, we expressed
PA-GFP-tagged MOV10 in hippocampal neurons and then
stimulated these neurons after pretreatment with lactacystin
(10 mM, 10 min). The MOV10-PA-GFP complex was immunopre-
cipitated from neuronal lysates using an antibody against GFP,
and the ubiquitination of MOV10 was visualized with an antibody
that specifically recognizes polyubiquitin conjugates (Fujimuro
et al., 1994). High molecular weight polyubiquitin labeling was
observed (Figure 1G), confirming that activity-regulated MOV10
degradation occurs through the ubiquitin pathway.
Single-Puncta Analysis of MOV10 Degradation following
KCl Depolarization
We imaged rat hippocampal neurons expressing MOV10-PA-
GFP. Upon depolarization with KCl (60 mM, 5 min), we observed
a rapid loss of fluorescence over the ensuing 45min (Figures 2A–
2D). We extracted the time profiles of the loss in fluorescence
intensity for 1500 puncta (from five neurons) and generated
a time constant distribution drawn from individual puncta
behavior. From those profiles, degradation appeared to be
a first-order reaction. Under basal conditions, i.e., without any
stimulation, the loss of fluorescence occurred with an exponen-
tial distribution that had a mean time constant of 25 min. This
distribution suggested individual fluorescent loss events were
independent and uncoordinated, i.e., relied on a Poisson
process (Figure S3). Following KCl treatment, the loss of fluores-
cent signal from the puncta appeared to be coordinated, as
degradation rates were drawn from a Gaussian distribution.
We derived a mean MOV10 degradation time constant of 8.0 ±
2.9 min (mean ± SD) (Figures 2D and S3). Analysis of MOV10
degradation at early time points indicated no measurable time
lag between the onset of stimulation and the effective loss of
MOV10-PA-GFP fluorescence (data not shown), suggesting
that MOV10-PA-GFP was processed for degradation without
delay. The activity-dependent loss of MOV10-PA-GFP fluores-
cence was not due to diffusion (Supplemental Data).
The distribution of degradation time constants formed a long
tail. 45% of the puncta had estimated time constants >60 min
and thus exhibited no effective degradation. This result raised
the possibility that puncta are differentially degraded depending
upon their spatial location, perhaps in a distal-proximal gradient.
However, this was not true. Puncta degraded in a location-inde-
pendent manner (Figure 2E).
To visualize whether MOV10 degradation occurred at active
synapses, we imaged hippocampal neurons expressing
MOV10-PA-GFP stimulated with KCl (60 mM, 5 min) in the pres-874 Neuron 64, 871–884, December 24, 2009 ª2009 Elsevier Inc.ence of the membrane stain FM4-64 (1 mM, 1 min), which tags
active synapses (Figure 2F). We observed that 34.5% ± 4.7%
of MOV10-PA-GFP puncta colocalized with the dye FM4-64.
Moreover, we observed that MOV10 was indeed degraded in
the FM4-64-stained synapses (Figures 2F and 2G). We probed
whether endogenous MOV10 could be found in active synapses
(Figure S1G): the 78% ± 2.2% colocalization value with active
synapses was much higher than the 25% ± 1.6% colocalization
value of MOV10 with all synapses stained with PSD95. This
observation hints at a preferential recruitment of MOV10 to
active synapses. Taken together, our result suggests a direct
link between synaptic activation and MOV10 degradation.
NMDA-Dependent Degradation of MOV10
Because KCl depolarization affects many voltage- and ligand-
gated channels, we used NMDA to stimulate neurons. With
NMDA, we also derived a mean MOV10 degradation time
constant of 8.0 ± 2.7min (mean ± SD) (data not shown); however,
the Gaussian distribution was sharper than with KCl (p = 0.05,
Kolmogorov-Smirnov test), suggesting that the observed
MOV10 degradation events were due to amore restricted mech-
anism.
We also investigated the effect of NMDA receptor inactivation
by AP5 on the distribution of degradation rates. AP5 treatment
(50 mM, 50 min) and subsequent neuron depolarization with
KCl induced a significant decrease of the fraction of synaptic
sites that degraded MOV10 from 55% to 41% (p = 3.107,
Kolmogorov-Smirnov test) without altering the degradation time
constant (Figures 2H and 2I). NMDA receptor activation thus
appears to be a triggering factor for MOV10 degradation. The
broadand less specific effects ofKCl depolarizationmayaccount
for the incomplete inhibition of MOV10 degradation by AP5.
Proteasomal Control of Activity-Induced MOV10
Degradation
We next sought to determine changes in single MOV10 puncta
degradation rates following pretreatment with the proteasome
inhibitor lactacystin (10 mM, 10 min). Adding lactacystin with
KCl or NMDA broadened the Gaussian distribution and
increased the mean degradation time constant to 12 ± 3.7 min
(mean ± SD) for KCl (Figures 2H and 2I) and 12 ± 3.9 min
(mean ± SD) for NMDA (data not shown). These values signifi-
cantly differed from treatment with KCl alone (p = 0.02, t test)
or with NMDA alone (p = 0.00017, t test). We could rescale the
distribution of degradation time constants induced by stimula-
tion with and without lactacystin in order to yield indistinguish-
able distributions (p = 0.30 for NMDA stimulation, p = 0.56 for
KCl stimulation, Kolmogorov-Smirnov test, see Supplemental
Data). Therefore, the MOV10 degradation time constant is
proportional to the proteasome activity or availability. Changes
in local proteasome availability (Bingol and Schuman, 2006)
will thus have a direct effect on the capability of an individual
synapse to degrade MOV10.
A Translational Trap Captures mRNAs Regulated
by the RISC
AsMOV10 is considered a critical RISC component and involved
in miRNA-guided translational control (Chendrimada et al.,
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Figure 2. Neuronal Stimulation Triggers Proteasome-Mediated Localized Degradation of MOV10
(A) Time-lapse imaging of hippocampal neurons (DIV 21–24) expressingMOV10-PA-GFP under basal conditions or stimulatedwith KCl (60mM, 5min) and subse-
quent degradation of GFP-labeled MOV10. Scale bar, 10 mm.
(B and C) Temporal variation in the relative fluorescence intensity of randomly chosen puncta from KCl-stimulated neuron: the locations of the puncta were iden-
tified with a circle (B) of the same color as the fluorescence trace (C). The white rectangle in (B) corresponds to the dendrite shown in (A). MOV10-PA-GFP degra-
dation occurred on the 10 min timescale. Scale bar, 20 mm.
(D) Temporal variation in the total relative fluorescence intensity of1500 puncta with (solid blue line) or without (dotted blue line) KCl stimulation. The distribution
of degradation time constants over all puncta could be adjusted (red lines) to a population of puncta degrading with a rate drawn from an exponential distribution
(absence of stimulation) or from a Gaussian distribution (KCl stimulation). See Figure S3 for details. Shades represent mean ± SEM.
(E) Median degradation time constant (red line) plotted against the distance of individual puncta from an arbitrary point. Time constants of individual puncta are
shown as blue dots. MOV10 degradation did not depend on the puncta location and was much faster than the relatively rare MOV10 degradation events under
basal conditions (black line: median degradation time constant).
(F and G) Simultaneous imaging of synaptic activity and MOV10-PA-GFP degradation upon KCl stimulation. (F) Neurons expressing MOV10-PA-GFP were stim-
ulated with KCl (60 mM, 5 min) in the presence FM4-64 (1 mM, 1 min). Active synapses showed 34.5% colocalization with MOV10-PA-GFP. (G) Temporal vari-
ations of the relative fluorescence intensity of MOV10-PA-GFP puncta shown in panel (F). No degradation was observed in puncta indicated with green arrows
(puncta showing no FM4-64 staining). MOV10-PA-GFP was degraded in puncta indicated with yellow arrows (puncta exhibiting FM4-64 staining). Scale bar,
20 mm.
(H) Proteasome block by lactacystin (10 mM, 10 min) or inhibition of the NMDA receptor by AP5 (50 mM, 50 min) inhibited MOV10-PA-GFP degradation. Scale bar,
10 mm.
(I) Distribution of time constants of individual puncta with KCl stimulation. Proteasome inhibition with lactacystin slowed the degradation. Inhibition of NMDA
receptors with AP5 induced a decrease in the number of MOV10-degrading puncta. Time constants <2 min cannot be measured with our imaging frequency.
Error bars indicate statistical error.
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MOV10 Degradation and Translational Silencing2007), like its fly ortholog Armitage (Cook et al., 2004; Tomari
et al., 2004), the loss of MOV10 could relieve translational
silencing. We hypothesized that with neuronal activation, a set
of mRNAs silenced by the RISC would be released into an
actively translating polysome pool in the synaptodendritic
compartment and elsewhere. We designed a translational trap
method to screen mRNAs that are actively translated after the
loss of MOV10. We disrupted RISC function with RNAi
constructs against MOV10 and then fractionated the actively
translating mRNAs using density gradient centrifugation. The
fractionation profile showed a reduced monosomal peak andincreased polysomal fraction (Figures 3A and 3B). We then iden-
tified the translationally upregulated mRNAs enriched in the
polyribosomal fraction by quantitative PCR. We selected 54
candidates based on their synaptodendritic localization (Poon
et al., 2006; Zhong et al., 2006), the presence of a conserved
miRNA seed match in their UTR, and a context score value
from Targetscan 4.0. Those candidate mRNAs enriched in the
polyribosomal fraction following MOV10 knockdown by RNAi
points to a pool of mRNAs that are regulated by miRNAs at
the level of translation initiation. 24% of the tested candidate
mRNAs showed a 2-fold enrichment in the actively translatingNeuron 64, 871–884, December 24, 2009 ª2009 Elsevier Inc. 875
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Figure 3. Translational Regulation of Dendritic mRNAs by the RISC
(A and B) A254 profile of ribosomal fractionation after RNAi knockdown of MOV10. Cortical neurons were transduced with lentiviral RNAi construct against MOV10
or a nontargeting control construct (Universal Control) at DIV 7–8. Cytosolic extracts (from neurons at DIV 18–19) were fractionated with continuous monitoring at
254 nm. UntranslatedmRNAs accumulated in the lighter monosomal fraction (M), whereas translatingmRNAswere captured in the heavier polysomal fraction (P).
(C) RNAi againstMOV10 upregulated the translation of a group of selected dendriticmRNAs. These candidateswere enriched in the polysomal fraction compared
to the universal control.
(D) RNAi against MOV10 upregulated a-CaMKII and Lypla1 protein levels.
(E) Quantification of the experiments shown in (D) (n = 2). Data shown as mean ± SEM, *p < 0.05, t test.
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MOV10 Degradation and Translational Silencingpolyribosomal fraction after RNAi against MOV10 (Figure 3C).
Among the top changing mRNAs, our screen identified two
known mRNAs whose translation is known to be regulated by
the RISC: Limk1 and a-CaMKII (5.5- and 3-fold change, respec-
tively, Figure 3C). On the other hand, several dendritic mRNAs
such as b-actin (ActB), translation initiation factors Eif3S9 and
Eif3S10, protein phosphatase 1 (Ppp1r9b), and others did not
change (less than 1.5 fold) after RNAi knockdown of MOV10
(Figure 3C). Thus, our screen specifically identified candidate
mRNAs that could be potentially regulated by the RISC.
Among the top changing mRNAs was Lypla1, with a 2-fold
change. Lypla1, also known as acyl protein thioesterase 1
(APT1), removes palmitate groups from proteins, including
endothelial nitric-oxide synthase (Yeh et al., 1999), Ga, and p21
(Duncan and Gilman, 1998). Palmitoylation is a reversible post-876 Neuron 64, 871–884, December 24, 2009 ª2009 Elsevier Inc.translational modification that has recently been implicated in
synaptic plasticity (el-Husseini and Bredt, 2002) and synaptic
development (Kang et al., 2008; Mukai et al., 2008). In addition
to the translational trap result, we confirmed the increase of
Lypla1 and a-CaMKII protein levels after knocking down
MOV10 (Figures 3D and 3E). Taken together, these observations
further support our hypothesis that activity-regulated proteaso-
mal control of MOV10 degradation may lead to localized transla-
tion of these mRNAs.
Lypla1 andmiR-138Are aRegulatedDuplex inDendrites
We tested our hypothesis that activity-regulated local proteaso-
mal control of MOV10 degradation leads to localized trans-
lation of mRNAs with Lypla1 as a potential candidate. The
30UTR of Lypla1 contains a conserved 8-mer seed match of
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Figure 4. Lypla1 Is a Target of Brain-Enriched microRNA, miR-138
(A) Luciferase activity was measured from hippocampal neurons (DIV 7) transfected with Lypla1 30UTR fused luciferase reporter construct in the presence of lock
nucleic acid (LNA) inhibitor of miR-138 or a nontargeting inhibitor (25 nM, 50 nM, and 100 nM). A luciferase assay was performed after 48 hr. Data shown as
mean ± SEM, n = 3, *p < 0.05, t test.
(B) The luciferase assay was performedwith wild-type andmutant Lypla1 30UTR tomonitor the effect of miR-138 binding site on reporter expression.Wild-type or
mutant Lypla1 30UTR was transfected into hippocampal neurons (DIV 7), and a reporter assay was performed 48 hr after transfection. Data shown as mean ±
SEM, n = 9, *p < 0.05, t test.
(C) LNA miR-138 enhances endogenous protein levels of Lypla1. LNA inhibitor of miR-138 and control LNA (25 nM, 50 nM, and 100 nM) were transfected into
hippocampal neurons (DIV 7). Neuronal lysates were prepared from LNA-treated samples after 48 hr. Data shown as mean ± SEM, n = 3, *p < 0.05, t test.
(D) Inhibition of miR-138 has no effect on the stability of Lypla1mRNA asmeasured by quantitative PCR. LNA inhibitor of miR-138 and control LNA (25 nM, 50 nM,
and 100 nM) were transfected into hippocampal neurons (DIV 7). Transcript levels weremeasured after 48 hr of LNA treatment. Data shown asmean ± SEM, n = 3,
*p < 0.05, t test.
(E) Both miR-138 and Lypla1 mRNA are localized at synapses. Double in situ hybridization of hippocampal neurons (DIV 21) using LNA probes for miR-138 and
Lypla1 mRNA and immunostained for the synaptic marker synapsin I. 32% of the synapses possessed both miR-138 and Lypla1 mRNA. Scale bar, 10 mm.
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MOV10 Degradation and Translational Silencinga brain-enriched microRNA, miR-138 (Lagos-Quintana et al.,
2002). Inhibition of endogenous miR-138 by lock nucleic acid
(LNA) in hippocampal neurons led to a significant increase of Ly-
pla1 30UTR fused luciferase reporter expression (80% ± 2%
increase, p = 0.0003, t test) as well as endogenous protein level
(90% ± 23% increase, p = 0.05, t test) compared to a control
LNA inhibitor (Figures 4A and 4C, respectively). Mutation in the
seed region of the predicted miR-138 binding site in Lypla1
30UTR also increased the luciferase reporter expression (2-fold
increase; p < 0.05, t test, Figure 4B). LNA-mediated inhibition
of miR-138 did not change the endogenous Lypla1 mRNA level
(Figure 4D), suggesting that miR-138 regulates Lypla1 expres-
sion at the translational level rather than at the level of mRNA
decay.
We next examined whether miR-138 and Lypla1 mRNA could
be found at the same synapses using double in situ hybridization
combined with immunostaining with scrambled probes as
controls (Figures S4A–S4D). 32% of synapsin I-positive puncta
were labeled with a miR-138 and Lypla1 mRNA probes (Figures
4E and S4E). In separate colocalization studies, we observed
that MOV10 colocalized with Lypla1 mRNA (60%) (Figure S4F).
Together these observations led us to reason that activity-regu-lated inactivation of a functional RISC through proteasomal
degradation of MOV10 will subsequently release the silenced
miRNA-bound Lypla1 mRNA for translation at dendritic spines
with spatiotemporal precision.
Single-Puncta Analysis of Local Dendritic
Protein Synthesis
To investigate whether activity-dependent proteasomal control
of the RISC is linked to new protein synthesis at synaptic sites,
we expressed the a-CaMKII and Lypla1 30UTRs fused to the
photoconvertible translation reporter, Kaede (Leung et al.,
2006; Raab-Graham et al., 2006), in hippocampal neurons.
Kaede had a punctate pattern when its expression levels were
low and a more uniform pattern once expression levels became
high (data not shown). We studied diffusion properties of Kaede
by FRAP (Supplemental Data) and found that Kaede behavior
was governed by an unbinding reaction and not by free diffusion.
These features were probably due to Kaede’s tetrameric nature
that leads to aggregates even at low concentration (Ando et al.,
2002; Dittrich et al., 2005). The special geometric properties of
a synapse, i.e., a restricted space, could also contribute to the
aggregate formation.Neuron 64, 871–884, December 24, 2009 ª2009 Elsevier Inc. 877
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Figure 5. Proteasomal Control of Localized Synthesis of a-CaMKII and Lypla1 mRNA
(A and B) Neuronal activity induced a-CaMKII 30UTR-mediated local synthesis of the translation reporter Kaede. Hippocampal neurons (DIV 14) were transduced
with a lentiviral construct containing Kaede fused to the 30UTR of a-CaMKII. Kaede was photoconverted, and then the neurons (DIV 21–24) were stimulated with
NMDA (20 mM, 5 min). Time-lapse images were collected to track new protein synthesis. Upon stimulation, puncta were either synthesizing new proteins (green
arrows) or not (white arrows). Scale bar, 10 mm. Neuronal processes are shown as outline. The temporal variations of the relative fluorescence intensity for
randomly chosen puncta (encircled in A) are shown in (B).
(C) Median synthesis time constant (red line) plotted against the puncta distance from an arbitrary point. Time constants of individual puncta are shown as blue
dots. a-CaMKII 30UTR-driven Kaede synthesis did not depend on puncta location.
(D) Synaptic activation induced localized new synthesis of Lypla1 30UTR-driven translation reporter. Hippocampal DIV 21–24 neurons transduced with lentiviral
construct (at DIV 16–18) containing Kaede fused to the 30UTR of Lypla1 were stimulated with glutamate (20 mM for 5min) after photoconversion of the Kaede.
Time-lapse images were collected to track new protein synthesis. Upon stimulation, puncta were synthesizing new proteins (green arrows) or not (white arrows).
Neuronal processes are shown as outline. Scale bar, 10 mm.
(E) Temporal variation of the total relative fluorescence intensity of1500 puncta under basal conditions (black line) or upon glutamate stimulation (dark blue line).
Anisomycin (green line) (40 mM, 20 min) and lactacystin (red line) (10 mM, 10 min) completely blocked new protein synthesis. New synthesis was not affected by
actinomycin D (light blue line) (5 mM, 10 min). The variation could be adjusted (dotted lines) to a population of synapses synthesizing Kaede with a time constant
drawn from a Gaussian distribution with the same mean as a-CaMKII 30UTR (Figure S5B). Shades represent mean ± SEM.
(F) Activity-dependent proteasomal degradation ofMOV10 is critical for localized protein synthesis of RISC-regulated candidatemRNA. After RNAi knockdown of
MOV10, hippocampal neurons expressing Lypla1 30UTR-fused Kaede were imaged for 20 min to record the level of basal Kaede fluorescence and then stimu-
lated with glutamate (20 mM, 5 min). After stimulation, neurons were further imaged for 20 min. A temporal profile of the total relative fluorescence intensity under
basal conditions as well as upon glutamate stimulation obtained from neurons after RNAi knockdown of MOV10 (dark blue line) showed no activity-dependent
increase of localized translation as compared to neurons without RNAi knockdown of MOV10 (red dotted line). Shades represent mean ± SEM.
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MOV10 Degradation and Translational SilencingAs NMDA receptor activation was sufficient to trigger
MOV10 degradation, we examined whether its activation could
induce local protein synthesis by recording the temporal varia-
tions of green Kaede fluorescence for 60 min in1500 individual
puncta. After NMDA activation (20 mM, 5 min), the a-CaMKII
30UTR-driven Kaede reporter indicated that new protein
synthesis, as monitored by the appearance of green Kaede fluo-
rescence, occurred with a time constant of 11 min, i.e., after 11
min the increasing fluorescence intensity began to plateau
(Figures 5A and 5B). To ensure that the signal increase was not
due to an enlargement in spine volume, we imaged the temporal
variation of fluorescence of the photoconverted Kaede proteins
in the red channel before stimulation and for 30min after stimula-
tion: we observed that the red signal remained constant over time
(data not shown); this could be explained by the lack of diffusion
of Kaede due to its propensity to aggregate.
Twopopulationsofpunctawereapparent: one inwhichactivity-
dependent synthesis occurred and one in which Kaede fluores-
cence was unchanged (Figure 5B). Those two populations were
not regionally localized within the neuron, as neighboring puncta
could belong to either population (Figures 5A and 5B). Like for
MOV10 degradation, we studied whether local protein synthesis
occurred in a spatially regulated way. We plotted the median
synthesis time constant as a function of the distance between878 Neuron 64, 871–884, December 24, 2009 ª2009 Elsevier Inc.each punctum and a single arbitrary point. We found that the
median synthesis timeconstant wasuniform regardless of puncta
locationwith a variation of15% (11.4± 1.1min [median±SD] for
a-CaMKII UTR and NMDA stimulation, Figure 5C).
Similar protein synthesis events upon NMDA stimulation were
observed with the Lypla1 30UTR-driven Kaede reporter (data
not shown). Glutamate (20 mM, 5 min) stimulation of neurons
expressing Lypla1 30UTR fused Kaede also induced a 20% local
increase in the relative amount of the translation reporter
compared to the basal level within 11 min of synaptic activation
(Figures 5D, 5E, and S5C). The timescale and the amount of
protein synthesis were in good agreement with previously
reported values in the literature, with different translation
reporters such as membrane-anchored GFP with a 1 hr half-
life (Aakalu et al., 2001) or Kaede (Leung et al., 2006). We found
that the protein synthesis kinetics and amount did not depend
significantly on the stimulationmethod (KCl, 60mM, 5min; gluta-
mate, 20 mM, 5 min; or NMDA, 20 mM, 5 min) or the UTR reporter
used (a-CaMKII or Lypla1).
Pretreatment with anisomycin (40 mM, 20 min), a protein-
synthesis inhibitor, completely blocked on-site reporter syn-
thesis (Figures 5E, S5B, and S5D). Pretreatment with actino-
mycin D (5 mM, 10 min), a transcription inhibitor, did not affect
new synthesis of the translation reporter (Figure 5E). It suggested
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Figure 6. Degradative Control of RISC Regulates Localized Synthesis of Lypla1 30UTR Fused Translation Reporter
(A) Localization of ectopically expressed MOV10 and Kaede fused with Lypla1 30UTR. Hippocampal neurons (DIV 14) were transduced with MOV10-CFP and
Kaede-Lypla1 30UTR and imaged (DIV 21) before stimulation. MOV10-CFP colocalized with Kaede reporter fused with Lypla1 30UTR. Scale bar, 20 mm.
(B) Distribution of degradation amplitudes in puncta synthesizing Kaede (black line) or not (gray line). Puncta that were synthesizing Kaede exhibited a stronger
overall MOV10 degradation (p = 3 3 1011, Kolmogorov-Smirnov test).
(C) Comparison between Kaede synthesis amplitude andMOV10 degradation amplitude in individual puncta. The red line shows themedian synthesis amplitude.
Those quantities were correlated (r = 0.5). A greater extent of MOV10 degradation tended to foster new protein synthesis.
(D) Comparison between Kaede synthesis time constants tsynthesis and MOV10 degradation time constants tdegradation in individual puncta. Synthesis time
constants depended only weakly on degradation time constants (red line shows the median synthesis time constant). See Supplemental Data for details
(Figure S6).
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MOV10 Degradation and Translational Silencingthat local translation at the synapse was not dependent on the
longer timescale of transcription.
Activity-Dependent Protein Synthesis Is MOV10
and Proteasome Dependent
The experiments described above correlate, but do not directly
link an activity-related increase in local translation to degradative
control of MOV10. Therefore, we repeated measurements of
activity-induced Lypla1 30UTR-mediated synthesis of Kaede
after RNAi knockdown of MOV10 in hippocampal neurons. We
first monitored the basal level of Kaede in these neurons for
20 min, then stimulated with glutamate (20 mM, 5 min), and
we imaged these neurons for a further 20 min. We observed
that RNAi-mediated loss of MOV10 abrogated the glutamate-
induced increase of Kaede fluorescence (Figure 5F). This obser-
vation confirmed our hypothesis that localized synthesis of
Lypla1 mRNA is directly linked to the integrity of MOV10.
Consistent with our hypothesis that proteasome-mediated
MOV10 degradation is required for release from translational
silencing, we observed that pretreatment of neurons with lacta-
cystin (10 mM, 10 min) blocked Lypla1 30UTR-driven new protein
synthesis from the Kaede reporter upon stimulation with
glutamate (20 mM, 5 min, Figures 5E and S5E). In similar experi-
ments using the Kaede reporter fused to the a-CaMKII 30UTR,
the total relative amount of synthesis was reduced by 30%
(p < 104, Wilcoxon test) upon NMDA stimulation (20 mM,
5 min) as compared to stimulation without lactacystin pretreat-
ment (Figures S5A and S5B). The less profound effect of the
proteasome inhibitor on the a-CaMKII 30UTR-driven reporter
translation could be due to additional translation control mecha-
nism, such as cytoplasmic polyadenylation (Wu et al., 1998).
Coordinated Degradation and Synthesis
in Single Puncta
To pinpoint more precisely the correlation between MOV10
degradation and new protein synthesis, we coexpressedMOV10fused with CFP and the Kaede-Lypla1 30UTR translation reporter
in hippocampal neurons. Both proteins, MOV10-CFP and the
Kaede-Lypla1 reporter, colocalized (Figure 6A). We stimulated
neurons with KCl (60 mM, 5 min) and imaged MOV10 degrada-
tion in the blue channel and Kaede synthesis in the green
channel. We measured time constants and amplitudes for
MOV10 degradation and the synthesis of the Lypla1 30UTR-
driven translation reporter in individual puncta.
This analysis led us to sort individual puncta into four
categories depending on their degradation/synthesis kinetics
(Table 1): (1) puncta in which both MOV10 degradation and
Lypla1 30UTR-mediated synthesis of translation occurred (17%);
(2) puncta in which MOV10 was degraded without any reporter
synthesis (31.6%); (3) puncta inwhich synthesis of the translation
reporter occurredwithoutMOV10 degradation (6.9%); (4) puncta
with essentially neither MOV10 degradation nor synthesis of
the translation reporter, i.e., time constants >60 min (44.5%).
Interestingly, of the synapses where MOV10 degradation took
place, 35% synthesized new proteins. Consistent with this
observation, data from the double in situ hybridization (Figure 4E)
showed that a similar fraction of synapses (32%) contained both
miR-138 and Lypla1 mRNA. Synthesis occurred in a significantly
lower fraction of the puncta without MOV10-CFP degradation,
and therefore, either other mechanisms contribute to regulate
local protein synthesis (Costa-Mattioli et al., 2009) or degrada-
tion of unlabeled endogenous MOV10 has occurred in this
population. Thus, MOV10 degradation dramatically increased
the fraction of puncta where protein synthesis took place.
Consistent with that observation was that puncta synthesizing
Kaede degraded more MOV10 (Figure 6B). Indeed, the ampli-
tudes of MOV10 degradation and Kaede synthesis in those
puncta where both processes occurred were correlated (r = 0.5,
Figure 6C). Interestingly, in those puncta where both MOV10
degradation and protein synthesis occurred, the rate of protein
synthesis exceeded the rate of MOV10 degradation in 56% of
the puncta (Figure 6D). This observation is compatible with theNeuron 64, 871–884, December 24, 2009 ª2009 Elsevier Inc. 879
Table 1. The Simultaneous Monitoring of MOV10 Degradation
and Lypla1 30UTR-Driven Kaede Synthesis Allowed Us to Define
Four Classes of Synapses
Neuron
MOV10 Degradation and Translational Silencingdifferential kinetics of MOV10 degradation as reported by loss of
the GFP signal, which occurs on the minute timescale, and the
rapid onset of Kaede synthesis.Puncta Characteristics Fraction
All Puncta
Puncta degrading MOV10 48.6%
Puncta not degrading MOV10 51.4%
Puncta synthesizing Kaede 23.9%
Puncta not synthesizing Kaede 76.1%
Puncta degrading MOV10 and synthesizing Kaede 17.0%
Puncta degrading MOV10 and not synthesizing Kaede 31.6%
Puncta not degrading MOV10 and synthesizing Kaede 6.9%
Puncta not degrading MOV10 and not synthesizing Kaede 44.5%
MOV10 Degrading Puncta
Puncta synthesizing Kaede 35.0%
Puncta not synthesizing Kaede 65.0%
Puncta Not Degrading MOV10
Puncta synthesizing Kaede 13.4%
Puncta not synthesizing Kaede 86.6%
Kaede Synthesizing Puncta
Puncta degrading MOV10 71.1%
Puncta not degrading MOV10 28.9%DISCUSSION
The experiments presented here demonstrate that the RISC
protein MOV10 is a pivotally positioned control element in the
regulation of local protein synthesis in dendrites. By suppressing
MOV10withRNAi, we set a translational trap to capture anmRNA
repertoire regulated by themiRNA system. Among thesemRNAs
was Lypla1, a depalmitoylating enzyme, and its miRNA silencer,
miR-138. Palmitoylation is a widely used modification of
many synaptic proteins, including Cdc42, that can potentially
regulate postsynaptic structures (Kang et al., 2008). Interestingly,
miR-138-mediated regulation of Lypla1 can also modulate spine
morphology through Rho-dependent pathways (Siegel et al.,
2009). In addition to the depalmitoylating enzyme, Lypla1, two
palmitoylating enzymes, Zdhhc2 and Zdhhc17, appeared in our
screen. Thus, activity-dependent regulation of the synthesis of
these palmitoylating and depalmitoylating enzymes represents
an important facet of the mRNA repertoire under the control of
the RISC in the context of synaptic stimulation. Among the
mRNAs found in the screen was the activity-dependent micro-
RNA target—Limk1—which can modulate structural and func-
tional plasticity by targeting cytoskeletal effectors (Schratt
et al., 2006). Taken together, the set of mRNAs that are relieved
of their silence (Figure 3C) represents a coordinately regulated
response to synaptic stimulation. Whether changes in the levels
of these enzymes are rate limiting will be important when weigh-
ing the broader functional significance of these findings.
Just under half the MOV10 puncta underwent degradation
following neuronal activation (Table 1). Those puncta in which
MOV10 did not degrade following activationmay reside in a func-
tionally incompetent pool due to saturation from overexpression.
Those puncta that degraded MOV10 without concomitant
synthesis may contain endogenous mRNAs that are not tagged.
Protein synthesis in the absence of MOV10 degradation was
relatively uncommon. The known distal-proximal NMDAgradient
(Major et al., 2008) was not evident in the broad pattern of
NMDA-induced MOV10 degradation. The likely reasons are (1)
our bath application of NMDA may saturate its endogenous
concentration, and (2) we used cultured hippocampal neurons
as opposed to neocortical pyramidal neurons on which such
gradients have been described.
Many telltale signs of protein degradation at the synapse have
been noted. Among these signs are the association of ubiquitin
ligaseswith synapses (Hegdeet al., 1997) andactivity-dependent
movement of the proteasome into the spine (Bingol and Schu-
man, 2006), but few specific substrates have been described.
Degradation of spine-associated Rap guanosine triphosphatase
activating protein (SPAR), PSD-95, and Bassoon were linked to
the induction of serum-inducible kinase (SNK) (Pak and Sheng,
2003), and in Drosophila, ubiquitin-dependent mechanisms
regulate synaptic development at the neuromuscular junction
(DiAntonio et al., 2001; Fulga and Van Vactor, 2008). The
discovery of MOV10 as ubiquitin-dependent client protein880 Neuron 64, 871–884, December 24, 2009 ª2009 Elsevier Inc.degraded by the proteasome presents a counterintuitive role for
degradation. In this case, degradation is linked to increased
local mRNA translation and thus an increase in the levels of those
proteins regulated in the RISC (Figure 7). Degradation of MOV10
and possibly other components of the RISCmay underlie obser-
vations that both degradation and synthesis are required for
synaptic plasticity (Ashraf et al., 2006; Fonseca et al., 2006).
MOV10 is functionally required to mediate miRNA-guided
mRNA cleavage (Meister et al., 2005). Tomari et al. (Tomari
et al., 2004) proposed that Drosophila Armi facilitates the ATP-
dependent incorporation of siRNA into the RISC, and its associ-
ation/dissociationwith the core RISC serves as a control element
over RISCmaturation and competence. Interestingly, Cook et al.
(Cook et al., 2004) showed Armitage function in translational
regulation of oskar and kinesin heavy chain mRNAs and also
suggested miRNA regulation of these mRNAs. The high
homology in the helicase domain between MOV10 and Armitage
suggests functional conservation.
Many possible activity-related changes in the structure of
the RISC could lead to dissociation of MOV10 from the RISC,
and these changes could precede the measured experimental
end point of MOV10 degradation. MOV10 degradation requires
that the protein is recognized by an as yet unknown ubiquitin
ligase and is delivered to the proteasome. MOV10 degradation
kinetics appeared as first order, indicating that the pool of
MOV10 destined to be degraded interacted with the degradation
machinery on the minute timescale, whereas Kaede synthesis
rises rapidly after stimulation. The degradation time constant
we measured reflects the processing of MOV10 by the degrada-
tion machinery, which we showed is likely to depend on local
proteasome availability. It is in accordance with the rapid rise
of Kaede synthesis after stimulation.
mRNA
translating
mRNA
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proteasome-dependent
MOV10 degradation
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NMDA stimulation Figure 7. Model for NMDA-Mediated Pro-
teasomal Control of RISC-Regulated New
Synthesis of Dendritic mRNA
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MOV10 Degradation and Translational SilencingInterestingly, degrading MOV10 rather than recycling it places
distinct kinetic boundaries on the window of translational
competence at the synapse. While translation is relieved, the
polysomeswill be competent to synthesize a potentially comput-
able number of copies of a protein until resilenced by reformation
of the holo-RISC that includes MOV10. Ultimately, synaptic
plasticity will be understood in the context of a full repertoire of
local responses to neuronal activation. Variation in the comple-
ment of silencedmRNAs among different synapses and different
neurons will be a critical future direction.
EXPERIMENTAL PROCEDURES
Cell Culture
Rat hippocampal neuron cultures were prepared as described previously
(Goslin and Banker, 1991). Briefly, the hippocampus was removed from E18
rat embryos, dissociated neurons were plated at 2800–8850 cells/cm2 in
60mmdish containing five glass coverslips coatedwith poly-L-lysine (1mg/ml)
or 22 mm Willco glass bottom dishes (5000–6000 cells/cm2). Neurons were
cocultured with glial cells in Neurobasal medium containing B27 supplement
up to DIV 24. Similarly, cortical neuronal cultures were prepared from E18 rat
embryos, were plated onto poly-L-lysine-coated 150 mm dishes (9000–
10000 cells/cm2), and grown in Neurobasal medium containing B27 supple-
ment up to DIV 18–19.
Lentiviral and Mammalian Constructs
shRNAcassettes forMOV10andcontrolRNAiwere cloned into lentiviral vector,
pLVTHM, and pLKO.1 (Addgene). Translation reporters were constructed by
subcloning Kaede-a-CamKII/Lypla1 30UTR into lentiviral vector, pWPXL
(Addgene). MOV10-PA-GFP construct was obtained by inserting PA-GFP
cassette into pWPXL followed by insertion of MOV10 coding sequence before
PA-GFP cassette. Lentiviral MOV10-CFP, GFP-Ub, and GFP-UbKO constructs
were subcloned into pWPXL. A myc epitope-tagged MOV10 at its C terminus
was constructed by subcloning MOV10 coding sequence into pcDNA4/myc-
His A (Invitrogen). The luciferase reporter was constructed by inserting Lypla1
30UTR into pMIR-REPORT (Ambion). The mutant Lypla1 30UTR fused Kaede
was obtained by site directed mutagenesis.
Lentiviral Transduction
Lentiviruses were produced by cotransfection of HEK293T cells with transfer
vector (pLVTHM or pWPXL containing shRNA or fusion protein cassette,Neuron 64, 871–884, Drespectively), packaging plasmid psPAX2 and
envelop plasmid pMD2.G as described in www.
lentiweb.com. Titers were determined by infecting
293T cells followed by FACS analysis. Titers were
typically 1–33 107 TU/ml after virus concentration.
Lentiviral infection procedures were described in
Supplemental Data.
Polyribosomal Fractionation
and Quantitative PCR Analysis
Polyribosomal fractionation was performed as
described previously (Stefani et al., 2004) with
minor modification (see Supplemental Data). Poly-
ribosome-containing fractions were pooled, and
RNA was isolated by precipitation as well as Abso-
lutely RNA RT-PCR Miniprep kit (Stratagene).
Double-stranded cDNA was synthesized usingFirst Strand Superscript II kit (Invitrogen). Quantitative PCR (qPCR) was per-
formed on a 7500 Fast Real-Time PCR system using the SYBR-green-contain-
ing PCR kit (Applied Biosystems) with GAPDH and 18S rRNA as internal stan-
dard.
In Situ Hybridization
In situ hybridization was performed using antisense-Lock Nucleic Acid (LNA)
oligonucleotide (Exiqon) using digoxigenin-labeled (DIG Oligonucleotide
Tailing Kit, 2nd generation, Roche) Lypla1 and Scramble-mRNA probes or
biotin-labeled rno-miR-138 and Scramble-miR probes. After hybridization,
neurons were incubated with cy3-labeled anti-DIG antibody (Jackson
Immunoresearch). Synaptic localization of mRNA or miRNA was detected
by anti-synapsin I antibody (Chemicon). To visualize endogenous MOV10
colocalization with Lypla1mRNA, in situ hybridization was performed followed
by immunostaining with anti-MOV10 antibody (Bethyl Laboratories).
For dual in situ hybridization, neurons were first hybridized with biotin-
labeled rno-miR-138 probe followed by DIG-labeled Lypla1 probe. After
hybridization, probes were detected by FITC-conjugated anti-biotin (Jackson
Immunoresearch) and cy3-conjugated anti-DIG (Jackson Immunoresearch)
antibodies, respectively. Synaptic localization was detected as described
above. Detailed protocol for in situ hybridizations is described in Supplemental
Experimental Procedures.
Stimulation of Hippocampal Neurons
Hippocampal neurons at DIV 21–24 were used for stimulation experiments as
described previously (Bingol and Schuman, 2006) with minor modifications.
Prior to stimulation, neurons were incubated in HBS (290 mOSm) (110 mM
NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgCl2, 10 mM D-glucose, 10 mM
HEPES-NaOH pH 7.4) for 60 min. Neurons were stimulated for 5 min with
high KCl-HBS (same as HBS except for 55 mM NaCl and 60 mM KCl)
and HBS containing 20 mM NMDA or 20 mM glutamate. After stimulation,
neurons were recovered in HBS for 30–60 min. Neurons were pretreated
with AP5 (50 mM, 50 min), lactacystin A (10 mM, 10 min), anisomycin (40 mM,
20 min), actinomycin D (5 mM, 10 min) to antagonize NMDA, proteasome
activity, protein synthesis, and transcription, respectively. Antagonists re-
mained in the incubation media for the duration of the experiment. Western
blot analysis of stimulated neurons is described in Supplemental Experimental
Procedures.
Slice Stimulation
Hippocampal slices were stimulated as described previously (Bingol and
Schuman, 2006; Murase et al., 2002) with minor modifications. Briefly, slices
were stimulated with ACSF buffer containing KCl (60 mM, 10 min). Afterecember 24, 2009 ª2009 Elsevier Inc. 881
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MOV10 Degradation and Translational Silencingstimulation, slices were recovered in ACSF for 30 min. Slices were pretreated
with AP5 (50 mM, 60 min) and lactacystin (10 mM, 15 min) when needed. Stim-
ulated slices were then processed for synaptoneurosome preparation as
described previously (Rao and Steward, 1991). Synaptoneurosome fractions
were then analyzed by western blot analysis using antibodies against PSD95
(NeuroMab, clone K28/43), synapsin I (Chemicon), GFAP (Chemicon), histone
H1 (Chemicon), aCamKII (Chemicon), TUJ1 (Covance), and MOV10 (Bethyl
Laboratories and PTG lab).
Analysis of MOV10 Ubiquitination
Hippocampal neurons were infected at DIV 12–14 with lentivirus construct
expressing MOV10-PA-GFP. Neurons (DIV 21–24) were stimulated with KCl
(60 mM, 5 min). Neurons were pretreated with lactacystin (10 mM, 10 min)
and remained in the incubation media for the duration of the experiment. After
recovery, immunoprecipitation was performed according to the protocol
described in the GFP antibody (Clone 1E4 fromMBL International) data sheet.
Briefly, neurons were lysed in lysis buffer (50 mM Tris-HCl, pH 7.5, 250 mM
NaCl, 0.1% NP40, 2 mM EDTA, and 10% glycerol) containing protease inhib-
itor cocktail (complete mini EDTA free). The total protein quantity of the lysate
was measured by BCA protein assay kit (Pierce). MOV10-PA-GFP was immu-
noprecipitated from stimulated or unstimulated lysate (3 mg of total protein)
using anti-GFP antibody (30 mg). Immunoprecipitated MOV10-PA-GFP was
then probed with a specific antibody for polyubiquitin conjugates (clone FK1
from Biomol International) as well as GFP.
Immunocytochemistry
Neurons (DIV 21) were immunostained as described previously (Wu et al.,
1998) with minor modifications. Neurons were stained with antibodies against
MOV10 (Bethyl Laboratories), PSD95 (clone 6G6-1C9; ABR Affinity Biore-
agent), MAP2 (clone SMI-52; Covance), and GFP (clone 1E4; MBL Interna-
tional). Specificity of MOV10 antibody (Bethyl Laboratories) was analyzed by
a blocking peptide as well as shRNA-mediated RNAi against MOV10 (Figures
S1A and S1B and S2C and S2D). Imaging was performed on an Oympus
Fluoview FV500 microscope using an Olympus UPLFLN 403 NA = 1.3 oil-
immersion objective. Illumination conditions were kept constant throughout
each experiment and between experiments.
Live Imaging
Hippocampal neurons infected at DIV 14 with lentivirus constructs (MOV10–
PA-GFP, Kaede-a-CaMKII 30UTR, Kaede-Lypla1 30UTR, MOV10–CFP) were
stimulated at DIV 21–24. Prior to imaging, neurons were incubated in HBS
for 60 min, PA-GFP or Kaede were globally photoactivated by illumination
with a benchtop 365 nmUV lamp (8W365 nm, Spectroline) for 10min. Neurons
were identified prior to stimulation and their morphology checked immediately
after stimulation. Stimulation was carried out by applying KCl (60 mM),
N-methyl-D-aspartic acid (NMDA, 20 mM) or glutamate (20 mM) in HBS for
5 min. When needed, neurons were pretreated with (R)-2-amino-5-phospho-
nopentanoic acid (AP5, 50 mM, 50 min), lactacystin (10 mM, 10 min), anisomy-
cin (40 mM, 20 min), or actinomycin D (5 mM, 10 min). Neurons were washed in
HBS (with 50 mM AP5, 10 mM lactacystin, 40 mM anisomycin, or 5 mM actino-
mycin D when needed). Imaging was done at 30C on an Oympus Fluoview
FV500 confocal inverted microscope using an Olympus UPLFLN 403 NA =
1.3 oil-immersion objective. Illumination conditions were kept constant
throughout each experiment and between experiments. Images were taken
every minute for 45–60 min starting 1 min after the end of stimulation. To
monitor Kaede synthesis, the green form of Kaede was imaged after deter-
mining that stimulation did not induce any changes in the red channel (filters
were from Chroma or Semrock; 500/20 excitation, 515LP dichroic, 535/20
emission for the green channel; 532/22 excitation, 560LP dichroic, and
617/73 emission for the red channel).
To analyze activity-dependent translation after RNAi against MOV10, hippo-
campal neurons at DIV 7 were infected with lentivirus expressing shRNA
against MOV10. Neurons (DIV 17) were further infected with lentivirus express-
ing Kaede fused with Lypla1 30UTR and then stimulated at DIV 22. Prior to
stimulation, images were captured for 20 min. After stimulation with glutamate
(20 mM, 5 min), neurons were further imaged for 20 min.882 Neuron 64, 871–884, December 24, 2009 ª2009 Elsevier Inc.To visualize whether MOV10 was degraded at an activated synapse,
neurons were imaged for 10 min after stimulation and then stained with FM4-
64 dye (1 mM, 1 min). Neurons were further imaged for 15 min after FM4-64
staining.Image Analysis
Image analysis was done with custom-written scripts in Matlab (MathWorks).
First, images were corrected for any drift in the focal plane by comparing to the
first image of a series. We segmented the first image of a series. To do so, we
subtracted the average intensity of 183 18 pixel neighborhood considered as
background, the resulting image was filtered using a 23 2 pixel neighborhood
to reduce noise. Puncta were extracted from the resulting image by threshold-
ing. The thresholding value was chosen to avoid false positives. Puncta
positions were determined, and their intensity was computed for all images
by integrating the signal from the raw image over a 10 3 10 pixel neighbor-
hood. We measured photobleaching by imaging a neuron without stimulation
at a higher imaging frequency. Puncta intensities were then corrected for
photobleaching, and their temporal variation was adjusted using amonoexpo-
nential law. For Kaede, the puncta fluorescence intensity was normalized
to the green signal after photoconversion. For MOV10, the puncta fluores-
cence intensity was normalized to the signal after PA-GFP photoactivation
and neuronal stimulation in most of the cases. Data analysis was done with
custom-written scripts in Python. Modeling of MOV10 degradation and Kaede
synthesis is described in Supplemental Data.Statistical Analysis
We used two-tailed Student’s t test (Welch t test was used when appropriate)
to compare protein levels fromwestern blot experiments and quantitative PCR
experiment results. The Kolmogorov-Smirnov test was used to compare time
constant distributions and degradation or synthesis amplitudes distributions.
TheWilcoxon signed-rank test was used to compare Kaede synthesis extents.
Significance level was set at 0.05.SUPPLEMENTAL DATA
Supplemental Data include six supplemental figures, supplemental Experi-
mental Procedures, details of modeling for MOV10 degradation and local
protein synthesis and can be found with this article online at http://www.cell.
com/neuron/supplemental/S0896-6273(09)00939-8.ACKNOWLEDGMENTS
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